First generic version of Xeloda gets FDA approval for breast and colorectal cancers

[News]

The U.S. Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic), and metastatic breast cancer.

More... (http://www.news-medical.net/news/20130917/First-generic-version-of-Xeloda-gets-FDA-approval-for-breast-and-colorectal-cancers.aspx)